3 terminated. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
| Phase 1 | 2 | Terminated 2 |
Follow Adrenoleukodystrophy: new trials by email Literature Review of Adrenoleukodystrophy trials Research Report on Adrenoleukodystrophy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Administration of SBT101 Gene Therapy in Adult Patients With Adrenomyeloneuropathy (AMN) SBT101 Treatment - AMN, AMN Gene Mutation | Phase 1 / Phase 2 | Terminated | SwanBio Therapeutics, Inc. | 9 | 2022-11-17 | 2026-08-26 |
| Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders hematopoietic stem cell infusion - Hurler Syndrome (MPS I), Hurler-Scheie Syndrome | Phase 1 / Phase 2 | Terminated | Talaris Therapeutics Inc. | 3 | 2011-04-01 | 2023-04-12 |
| Effect of Glycerol Trierucate on Clinical Course of Adrenoleukodystrophy glyceryl trierucate/glyceryl trioleate - Adrenoleukodystrophy | Phase 2 | Terminated | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | 126 | 1998-04-01 | 2020-10-23 |
Metabolism, Inborn Errors (2) · Adrenal Insufficiency (1) · Brain Diseases, Metabolic (1) · Brain Diseases, Metabolic, Inborn (1) · Demyelinating Diseases (1) · Hereditary Central Nervous System Demyelinating Diseases (1) · Heredodegenerative Disorders, Nervous System (1) · Leukodystrophy, Globoid Cell (1) · Leukodystrophy, Metachromatic (1) · Leukoencephalopathies (1) · Metabolic Diseases (1) · Mucopolysaccharidosis I (1) · Mucopolysaccharidosis II (1) · Mucopolysaccharidosis III (1)
Adrenal Gland Diseases (3) · Brain Diseases (3) · Central Nervous System Diseases (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Endocrine System Diseases (3) · Genetic Diseases, Inborn (3) · Genetic Diseases, X-Linked (3) · Intellectual Disability (3) · Nervous System Diseases (3) · Neurobehavioral Manifestations (3) · Neurologic Manifestations (3) · Nutritional and Metabolic Diseases (3) · Pathological Conditions, Signs and Symptoms (3) · X-Linked Intellectual Disability (3) · Adrenal Insufficiency (2)
Lorenzo's oil (1) · Stem Cell Transplantation (1) · Triolein (1) · trierucate (1)
Hugo W. Moser Research Institute at Kennedy Krieger, Inc. (1) · SwanBio Therapeutics, Inc. (1) · Talaris Therapeutics Inc. (1)
United States (3) · Netherlands (1)
Gerald V Raymond, M.D. (1) · Suzanne T Ildstad, MD (1)